COMPANY INSIGHT

Demand for natural ingredients continues to drive interest in novel marine compounds. One marine compound of increasing interest to researchers and formulators alike is fucoidan. Naturally occurring in brown seaweeds and offering a range of bioactivities, high purity, certified organic fucoidans are now being utilised in market-leading nutritional formulations targeting immune support, gut and digestive health, and healthy ageing.

Innovative Australian biotechnology company Marinova Pty Ltd is recognised as the global leader in fucoidan science. The company’s reputation is built on the unrivalled quality and efficacy of its bioactive fucoidan extracts and two decades of rigorous scientific investigation. Marinova’s unique portfolio now boasts bioactive ingredients of unrivalled quality and efficacy.

CAROLINA D'INTRONA

Reckitt | Francia

Despite the long history of seaweeds as medicinal agents, it was not until the twentieth century that fucoidan was first isolated and recognised for its therapeutic potential. Once fucoidans became commercially available, global research into their unique bioactive properties increased significantly. There are now over 2500 scientific papers supporting the physiological benefits of these unique polysaccharides. As a result of this research, high purity fucoidan extracts are now used in a variety of applications including dietary supplements, medical devices, veterinary products and topical formulations for skincare and dermatology.

Marinova is home to the exclusive range of Maritech^® organic fucoidan extracts - high purity fucoidans developed specifically for nutritional, cosmetic and animal health applications. Maritech^® fucoidan is the world’s only high purity, certified organic fucoidan with global regulatory acceptance – including FDA notified GRAS and EU Novel Foods Approval. Efficacious and supported by an extensive dossier of scientific evidence, Maritech^® organic fucoidans represent the new frontier in natural marine ingredients.

Maritech^® organic fucoidans are supplied as a dry powder and are ideal for inclusion in bulk supplement powders, capsules, pressed tablets, creams, gels, serums and medical devices. They can be utilized as a stand-alone ingredient or easily incorporated with other ingredients. Maritech^® organic fucoidans are water soluble and have mild flavour profiles, providing flexibility for use in gels and functional beverages.

Manufacturers of fucoidan have traditionally utilised solvents to precipitate the fucoidan polymer from crude extracts. Fucoidans manufactured in this way can suffer from many shortfalls, including the possibility of residual solvents in the final extract. Their quality can also be inconsistent, their chemical integrity may be compromised and - most importantly - their bioactivity may be affected.

The Maritech^® extraction technology, developed and used exclusively by Marinova, overcomes these problems. The process does not use organic solvents and produces fucoidan extracts that remain unadulterated in chemical structure and free from solvent residues. The mild, aqueous process also ensures the resulting extracts comply with the most rigorous quality standards and regulatory requirements. Marinova’s stringent quality systems ensure batch-to-batch consistency and compliance with GMP, HACCP, ISO9001, Halal, Kosher and organic accreditations.

Marinova aligns its practices with key Sustainable Development Goals outlined by the United Nations. The company is a fervent protector of the marine environment and is committed to using wild-grown seaweeds - a rapidly renewable marine resource. Marinova only sources wild macro algae from the cleanest ocean waters and all harvesting operations are conducted in accordance with world’s best practice. The company does not source seaweeds that have been grown or farmed in parts of the world prone to industrial or human contamination or where environmentally sustainable harvesting practices cannot be assured.

Marinova’s world-class extraction facility successfully diverts all seaweed residues away from unproductive landfill and into new, value-added products. Not only does Marinova capture all liquid and solid by-products of its fucoidan extraction process, it converts these into nutrient-rich organic additives for the horticultural sector. The company’s fucoidan extraction facilities, scientific laboratories and administrative offices are all powered by renewable energy. The utilization of hydroelectricity and a customised state-of-the-art solar array places Marinova one step closer to being a legitimate zero-waste, carbon neutral manufacturer.

Australia is investing significantly in its innovative marine bioproducts industry. Marinova is a founding industry partner in the country’s $270M national Marine Bioproducts Cooperative Research Centre – a program fast tracking the growth of the Australia’s marine bio-industries. Speaking of the innovative consortium of industry, academic and government partners, Marinova’s CEO Mr Paul Garrott said, “Australia is increasingly being recognized as a world leader in the research and manufacture of high value marine bioproducts. We’re now working alongside partners who not only share our passion for improved health outcomes but also our vision for an expansive - and sustainable - marine bioproducts sector in Australia. The future opportunities for superior algal-derived products here are huge.”

FASCICOLO SPONSORIZZATO DA